Pharmacodynamic and pharmacokinetic properties of the combined preparation of levothyroxine plus sustained- release liothyronine; a randomized controlled clinical trial

被引：0
|
作者：
Ladan Mehran
Atieh Amouzegar
Seyed Mohsen Foroutan
Safdar Masoumi
Maryam Tohidi
Hengameh Abdi
Ali Aghaei
Amir Esmaeel Saghafinia
Fereidoun Azizi
机构：
[1] Shahid Beheshti University of Medical Sciences,Endocrine Research Center, Research Institute for Endocrine Sciences
[2] Shahid Beheshti University of Medical Sciences,Department of Pharmaceutics, School of Pharmacy
[3] Shahid Beheshti University of Medical Sciences,Protein Technology Research Center
[4] Shahid Beheshti University of Medical Sciences,Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences
[5] Noor Research & Educational Institute (TAVAN),undefined
来源：
BMC Endocrine Disorders | / 23卷
关键词：
Hypothyroidism; Clinical trial; Combination therapy levothyroxine; Liothyronine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 23 条
  • [21] Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal:: a randomized, double-blind, placebo-controlled, clinical trial with sustained release arnoxicillin/clavulanic acid (1000/62.5 mg)
    Lacasa, J. M.
    Jimenez, J. A.
    Ferras, V.
    Bossom, M.
    Sola-Morales, O.
    Garcia-Rey, C.
    Aguilar, L.
    Garau, J.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2007, 36 (04) : 321 - 327
  • [22] A randomized, double-blind, placebo-controlled, single, and multiple dose-escalation Phase I clinical trial to investigate the safety, pharmacokinetic, and pharmacodynamic profiles of oral S086, a novel angiotensin receptor-neprilysin inhibitor, in healthy Chinese volunteers
    Hu, Yue
    Zhang, Hong
    Li, Xiaojiao
    Mai, Jiajia
    Yang, Lizhi
    Yan, Jie
    Li, Ying
    Sun, Jingchao
    Xu, Wenjie
    He, Shiying
    Li, Jinfeng
    Wu, Min
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (09) : 977 - 985
  • [23] A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study)
    Kataoka, Kozo
    Tsushima, Takahiro
    Mizusawa, Junki
    Hironaka, Shuichi
    Tsubosa, Yasuhiro
    Kii, Takayuki
    Shibuya, Yuichi
    Chin, Keisho
    Katayama, Hiroshi
    Kato, Ken
    Fukuda, Haruhiko
    Kitagawa, Yuko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (05) : 494 - 498
123